Literature DB >> 2895936

Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.

A Viala1, B Ba, A Durand, F Gouezo, N Hou, A Jørgensen.   

Abstract

Seventeen outpatients were treated with depot neuroleptics, zuclopenthixol decanoate in Viscoleo or fluphenazine decanoate in sesame oil, with dosage intervals of 3 weeks. During the 4th, 6th, and 8th dosage interval blood samples were drawn in oxalated tubes. Plasma concentrations of the active neuroleptic drugs, zuclopenthixol and fluphenazine, were determined by high performance liquid chromatography. The concentrations indicated some interindividual as well as intraindividual variations. For zuclopenthixol the maximum concentration was most often seen at day 7 after injection, whereas the kinetics of the fluphenazine concentrations was more variable. There was an indication of more fluctuation in the 4th dosage interval than in the 8th dosage interval, possibly due to the fact that steady state has not yet been achieved at the 4th dosage interval.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895936     DOI: 10.1007/bf00174677

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate.

Authors:  S R Marder; E M Hawes; T Van Putten; J W Hubbard; G McKay; J Mintz; P R May; K K Midha
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.

Authors:  D H Wiles; M G Gelder
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

3.  Studies on the fate of vegetable oit after intramuscular injection into experimental animals.

Authors:  O Svendsen; T Aaes-Jørgensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-11

4.  [Determination of cis(Z)-clopenthixol and fluphenazine in whole blood and plasma by high-performance liquid chromatography with an internal standard].

Authors:  A Viala; N Hou; A Durand; B Ba; T Aaes-Jørgensen; A Jørgensen
Journal:  J Pharm Belg       Date:  1983 Nov-Dec

5.  Specific high-performance liquid chromatographic method for estimation of the cis(Z)- and trans(E)-isomers of clopenthixol and a N-dealkyl metabolite.

Authors:  T Aaes-Jørgensen
Journal:  J Chromatogr       Date:  1980-08-08

6.  Pharmacokinetic studies on clopenthixol decanoate; a comparison with clopenthixol in dogs and rats.

Authors:  T Aaes-Jorgensen; K F Overo; K P Bogeso; A Jorgensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-08

7.  Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.

Authors:  T R Barnes; D H Wiles
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.

Authors:  T Aaes-Jørgensen; L Kirk; E Petersen; P Danneskiold-Samsøe; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

10.  Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.

Authors:  A Jrgensen; K F Overø
Journal:  Acta Psychiatr Scand Suppl       Date:  1980
View more
  4 in total

Review 1.  [Long-acting injectable antipsychotics. Overview and advice for daily routine care].

Authors:  S Köhler; A Heinz; P Sterzer
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

Review 2.  Zuclopenthixol dihydrochloride for schizophrenia.

Authors:  Edward J Bryan; Marie Ann Purcell; Ajit Kumar
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

Review 3.  Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.

Authors:  E Coutinho; M Fenton; S Quraishi
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 4.  Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.

Authors:  Christoph U Correll; Edward Kim; Jennifer Kern Sliwa; Wayne Hamm; Srihari Gopal; Maju Mathews; Raja Venkatasubramanian; Stephen R Saklad
Journal:  CNS Drugs       Date:  2021-01-28       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.